May 6, 2022 08:00AM
May 2, 2022 08:00AM
Apr 25, 2022 01:15PM
Oct 26, 2020 08:00AM
Oct 5, 2020 08:00AM
Aug 5, 2020 08:30AM
Jun 15, 2020 08:00AM Sunovion Announces Health Canada Approval of KYNMOBI™ (apomorphine hydrochloride) Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
May 21, 2020 06:13PM
May 19, 2020 08:00AM
Apr 15, 2020 05:04PM
Mar 26, 2020 08:00AM
Dec 20, 2019 08:00AM
Dec 12, 2019 08:00AM
Nov 22, 2019 09:00AM Sunovion Resubmits New Drug Application for Apomorphine Sublingual Film
Nov 8, 2019 07:00AM
Sep 27, 2019 08:00AM
Sep 6, 2019 09:00AM
Sep 6, 2019 03:01AM
Jul 30, 2019 08:00AM
Jun 6, 2019 07:55PM
May 10, 2019 08:00AM Sunovion and PsychoGenics Announce that SEP-363856 Has Received FDA Breakthrough Therapy Designation for the Treatment of People with Schizophrenia
May 2, 2019 08:00AM
May 1, 2019 08:00AM
Jan 30, 2019 10:15PM
Sep 19, 2018 08:00AM
Sep 19, 2018 08:00AM
Sep 12, 2018 08:00AM
Aug 31, 2018 09:30AM FDA Issues a Complete Response Letter for New Drug Application for Dasotraline for the Treatment of ADHD
Jul 25, 2018 08:00AM
Jun 27, 2018 02:30PM
Jun 23, 2018 09:00AM
Jun 12, 2018 05:00PM
Jun 1, 2018 02:00PM
May 17, 2018 09:51AM
May 16, 2018 08:23AM Sunovion Announces Data Presentations Highlighting Broad Portfolio of Treatments for COPD at the American Thoracic Society International Conference 2018
May 2, 2018 08:00AM
Apr 25, 2018 08:30AM
Apr 20, 2018 11:34AM
Apr 3, 2018 08:00AM
Mar 30, 2018 08:00AM
Mar 6, 2018 03:37PM
Jan 29, 2018 04:30PM Sunovion Announces Positive Topline Results from Pivotal Study of Apomorphine Sublingual Film (APL-130277) in Patients with Parkinson’s Disease
Dec 5, 2017 08:48PM
Nov 29, 2017 08:00AM
Nov 10, 2017 10:30AM
Oct 31, 2017 08:00AM
Oct 27, 2017 04:00PM
Oct 24, 2017 08:00AM
Oct 19, 2017 08:11AM Sunovion Announces Seebri™ Neohaler® (glycopyrrolate) Inhalation Powder is Now Available in the United States
Oct 10, 2017 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All